Search research articles
Contact Us
Filters
Showing results (111-120 of 206) with videos related to
Page
of 21
Sort By:
Journal of Law and the Biosciences
|
October 2, 2025
Disparities in access to gene therapy in the European Union: ethical and regulatory challenges
Margaux Reckelbus, Riya Mohan, Phaedra Locquet, et al.
Frontiers in Pharmacology
|
October 15, 2025
Preferences for gene therapy in Duchenne muscular dystrophy: insights from patient and caregiver interviews and attribute development
Thomas Desmet, Lauren Van Haesendonck, Sophie Vermeire, et al.
BMC Medical Research Methodology
|
June 24, 2023
Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments
Robbe Saesen, Kevin Depreytere, Karyna Krupianskaya, et al.
Clinical Pharmacology and Therapeutics
|
April 3, 2020
The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review
Liese Barbier, Hans C Ebbers, Paul Declerck, et al.
Frontiers in Pharmacology
|
July 23, 2016
Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies
Evelien Moorkens, Clara Jonker-Exler, Isabelle Huys, et al.
Frontiers in Pharmacology
|
January 24, 2022
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
Yannick Vandenplas, Liese Barbier, Steven Simoens, et al.
Frontiers in Medicine
|
November 16, 2020
Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality
Teodora Lalova, Cristina Padeanu, Anastassia Negrouk, et al.
BMC Health Services Research
|
September 29, 2022
Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study
Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, et al.
ICES Journal of Marine Science : Journal Du Conseil
|
April 5, 2021
Strengthening the global network for sharing of marine biological collections: recommendations for a new agreement for biodiversity beyond national jurisdiction
Jane Eva Collins, Muriel Rabone, Thomas Vanagt, et al.
Frontiers in Pharmacology
|
February 4, 2025
Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviews
Thomas Desmet, Sissel Michelsen, Elena Van den Brande, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 206) with videos related to
Sort By:
Page
of 21
Journal of Law and the Biosciences
|
October 2, 2025
Disparities in access to gene therapy in the European Union: ethical and regulatory challenges
Margaux Reckelbus, Riya Mohan, Phaedra Locquet, et al.
Frontiers in Pharmacology
|
October 15, 2025
Preferences for gene therapy in Duchenne muscular dystrophy: insights from patient and caregiver interviews and attribute development
Thomas Desmet, Lauren Van Haesendonck, Sophie Vermeire, et al.
BMC Medical Research Methodology
|
June 24, 2023
Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments
Robbe Saesen, Kevin Depreytere, Karyna Krupianskaya, et al.
Clinical Pharmacology and Therapeutics
|
April 3, 2020
The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review
Liese Barbier, Hans C Ebbers, Paul Declerck, et al.
Frontiers in Pharmacology
|
July 23, 2016
Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies
Evelien Moorkens, Clara Jonker-Exler, Isabelle Huys, et al.
Frontiers in Pharmacology
|
January 24, 2022
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
Yannick Vandenplas, Liese Barbier, Steven Simoens, et al.
Frontiers in Medicine
|
November 16, 2020
Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality
Teodora Lalova, Cristina Padeanu, Anastassia Negrouk, et al.
BMC Health Services Research
|
September 29, 2022
Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study
Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, et al.
ICES Journal of Marine Science : Journal Du Conseil
|
April 5, 2021
Strengthening the global network for sharing of marine biological collections: recommendations for a new agreement for biodiversity beyond national jurisdiction
Jane Eva Collins, Muriel Rabone, Thomas Vanagt, et al.
Frontiers in Pharmacology
|
February 4, 2025
Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviews
Thomas Desmet, Sissel Michelsen, Elena Van den Brande, et al.
Page
of 21